BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 32 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 718,701 | $7,790,647 | 0.97% |
| BERKLEY W R CORP | 1,119,638 | $12,125,680 | 0.79% |
| First Trust Capital Management L.P. | 1,106,378 | $11,993,027 | 0.66% |
| COWEN AND COMPANY, LLC | 679,393 | $7,364,552 | 0.52% |
| Westchester Capital Management, LLC | 1,390,000 | $15,053,701 | 0.44% |
| METEORA CAPITAL, LLC | 235,256 | $2,550,152 | 0.44% |
| BCK CAPITAL MANAGEMENT LP | 74,268 | $805,058 | 0.41% |
| Exos TFP Holdings LLC | 60,000 | $650,400 | 0.35% |
| PERISCOPE CAPITAL INC. | 250,000 | $2,709,975 | 0.31% |
| FIR TREE CAPITAL MANAGEMENT LP | 230,111 | $2,492,102 | 0.26% |
| AQR Arbitrage LLC | 482,993 | $5,230,814 | 0.24% |
| MIZUHO SECURITIES USA LLC | 674,829 | $7,267,908 | 0.22% |
| KIM, LLC | 200,000 | $2,167,980 | 0.22% |
| GLAZER CAPITAL, LLC | 307,532 | $3,334 | 0.22% |
| UBS OCONNOR LLC | 453,158 | $4,907,701 | 0.12% |
| LINDEN ADVISORS LP | 1,000,000 | $10,830,000 | 0.11% |
| Atlas Merchant Capital LLC | 50,000 | $541,500 | 0.11% |
| Centiva Capital, LP | 426,937 | $4,623,728 | 0.10% |
| ARISTEIA CAPITAL, L.L.C. | 300,000 | $3,251,970 | 0.09% |
| Saba Capital Management, L.P. | 323,142 | $3,502,827 | 0.08% |
This page lists BIOPLUS ACQUISITION CORP's shareholders in Q3 2023. To view BIOPLUS ACQUISITION CORP's shareholder history, click here.